333 related articles for article (PubMed ID: 22594313)
1. Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2.
Garcia CB; Shaffer CM; Eid JE
BMC Genomics; 2012 May; 13():189. PubMed ID: 22594313
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2.
Garcia CB; Shaffer CM; Alfaro MP; Smith AL; Sun J; Zhao Z; Young PP; VanSaun MN; Eid JE
Oncogene; 2012 May; 31(18):2323-34. PubMed ID: 21996728
[TBL] [Abstract][Full Text] [Related]
3. The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1.
Barco R; Garcia CB; Eid JE
PLoS One; 2009; 4(4):e5060. PubMed ID: 19337376
[TBL] [Abstract][Full Text] [Related]
4. The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation.
de Bruijn DR; Allander SV; van Dijk AH; Willemse MP; Thijssen J; van Groningen JJ; Meltzer PS; van Kessel AG
Cancer Res; 2006 Oct; 66(19):9474-82. PubMed ID: 17018603
[TBL] [Abstract][Full Text] [Related]
5. Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cells.
Hayakawa K; Ikeya M; Fukuta M; Woltjen K; Tamaki S; Takahara N; Kato T; Sato S; Otsuka T; Toguchida J
Biochem Biophys Res Commun; 2013 Mar; 432(4):713-9. PubMed ID: 23313505
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1.
Cironi L; Provero P; Riggi N; Janiszewska M; Suva D; Suva ML; Kindler V; Stamenkovic I
PLoS One; 2009 Nov; 4(11):e7904. PubMed ID: 19936258
[TBL] [Abstract][Full Text] [Related]
7. Fusions of the SYT and SSX genes in synovial sarcoma.
Ladanyi M
Oncogene; 2001 Sep; 20(40):5755-62. PubMed ID: 11607825
[TBL] [Abstract][Full Text] [Related]
8. The synovial sarcoma translocation protein SYT-SSX2 recruits beta-catenin to the nucleus and associates with it in an active complex.
Pretto D; Barco R; Rivera J; Neel N; Gustavson MD; Eid JE
Oncogene; 2006 Jun; 25(26):3661-9. PubMed ID: 16462762
[TBL] [Abstract][Full Text] [Related]
9. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
Antonescu CR; Kawai A; Leung DH; Lonardo F; Woodruff JM; Healey JH; Ladanyi M
Diagn Mol Pathol; 2000 Mar; 9(1):1-8. PubMed ID: 10718206
[TBL] [Abstract][Full Text] [Related]
10. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
11. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
[TBL] [Abstract][Full Text] [Related]
12. The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway.
Barco R; Hunt LB; Frump AL; Garcia CB; Benesh A; Caldwell RL; Eid JE
Mol Biol Cell; 2007 Oct; 18(10):4003-12. PubMed ID: 17686994
[TBL] [Abstract][Full Text] [Related]
13. SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma.
Saito T; Nagai M; Ladanyi M
Cancer Res; 2006 Jul; 66(14):6919-27. PubMed ID: 16849535
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Wnt pathway in synovial sarcoma models.
Barham W; Frump AL; Sherrill TP; Garcia CB; Saito-Diaz K; VanSaun MN; Fingleton B; Gleaves L; Orton D; Capecchi MR; Blackwell TS; Lee E; Yull F; Eid JE
Cancer Discov; 2013 Nov; 3(11):1286-301. PubMed ID: 23921231
[TBL] [Abstract][Full Text] [Related]
15. SYT-SSX fusion genes in synovial sarcoma of the thorax.
Yano M; Toyooka S; Tsukuda K; Dote H; Morimoto Y; Ohata N; Ichimura K; Aoe M; Date H; Shimizu N
Lung Cancer; 2004 Jun; 44(3):391-7. PubMed ID: 15140553
[TBL] [Abstract][Full Text] [Related]
16. SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex.
Soulez M; Saurin AJ; Freemont PS; Knight JC
Oncogene; 1999 Apr; 18(17):2739-46. PubMed ID: 10348348
[TBL] [Abstract][Full Text] [Related]
17. The SYT-SSX fusion protein and histological epithelial differentiation in synovial sarcoma: relationship with extracellular matrix remodeling.
Saito T
Int J Clin Exp Pathol; 2013; 6(11):2272-9. PubMed ID: 24228088
[TBL] [Abstract][Full Text] [Related]
18. SYT-SSX fusion proteins in synovial sarcomas: detection and characterization with new antibodies.
Hashimoto N; Araki N; Yoshikawa H; Myoui A; Matsumine A; Kaneko M; Sonobe H; Ochi T
Cancer Lett; 2000 Feb; 149(1-2):31-6. PubMed ID: 10737705
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript.
Fligman I; Lonardo F; Jhanwar SC; Gerald WL; Woodruff J; Ladanyi M
Am J Pathol; 1995 Dec; 147(6):1592-9. PubMed ID: 7495284
[TBL] [Abstract][Full Text] [Related]
20. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins.
dos Santos NR; de Bruijn DR; Balemans M; Janssen B; Gärtner F; Lopes JM; de Leeuw B; Geurts van Kessel A
Hum Mol Genet; 1997 Sep; 6(9):1549-58. PubMed ID: 9285793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
